Bioleaders Corp. | Cash Flow
Fiscal year is January-December. All values KRW Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
3,221,330.80
1,361,254.10
18,639,165.80
5,895,692.30
6,646,862.00
Depreciation, Depletion & Amortization
746,413.70
663,593.00
502,625.10
428,415.40
615,235.00
Other Funds
302,577.60
2,031,665.50
-
-
-
Funds from Operations
2,167,774.60
2,913,087.40
4,214,016.30
5,147,085.40
5,696,482.60
Changes in Working Capital
749,030.00
2,219,733.90
614,568.90
1,059,448.70
2,828,790.00
Net Operating Cash Flow
1,418,744.60
5,132,821.30
4,828,585.20
6,206,534.20
8,525,272.60
Capital Expenditures
469,728.90
260,585.70
374,371.70
1,436,842.90
2,669,641.00
Sale of Fixed Assets & Businesses
500,000.00
5,004,500.00
-
7,454.50
58,030.70
Purchase/Sale of Investments
48,639.30
427,800.00
3,008,200.00
5,002,200.00
1,999,987.50
Net Investing Cash Flow
49,595.80
4,029,172.10
2,466,340.60
6,179,933.80
7,131,303.90
Issuance/Reduction of Debt, Net
1,890,000.00
2,905,000.00
514,400.90
705,000.00
-
Net Financing Cash Flow
1,587,422.40
6,211,578.80
3,414,936.20
16,812,333.60
24,143,066.90
Net Change in Cash
119,082.10
5,107,929.70
3,884,492.20
4,426,458.80
8,452,138.90
Free Cash Flow
1,448,051.40
5,253,262.50
5,051,799.60
7,245,170.80
11,114,144.40
Deferred Taxes & Investment Tax Credit
34,261.00
-
-
-
-
Net Assets from Acquisitions
-
-
-
-
1,500,000.00
Other Sources
16,247.50
7,374.00
1,699,320.60
1,699,446.50
1,067,506.90
Change in Capital Stock
-
7,084,913.30
3,929,337.10
17,517,333.60
24,143,066.90
Exchange Rate Effect
-
-
4,502.60
593.20
34,351.60
Other Uses
47,475.00
294,316.10
783,089.40
1,447,791.90
2,087,212.90
About Bioleaders
View Profile
